WHO ICTRP trial
AZD6244 in Children With Low-Grade Gliomas
NCT01386450 · NIH Clinical Trials · Recruiting
Key facts
| Trial ID | NCT01386450 |
|---|---|
| Public title | AZD6244 in Children With Low-Grade Gliomas |
| Scientific title | Phase 1 and Phase II and Re-Treatment Study of AZD6244 for Recurrent or Refractory Pediatric Low Grade Glioma |
| Primary sponsor | National Cancer Institute (NCI) |
| Registry | NIH Clinical Trials |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | Phase 1/Phase 2 |
| Countries | United States |
| Conditions | Fibriullary Astrocytoma;Optic Glioma;Pilocytic Astrocytoma;Low Grade Glioma |
| Interventions | Drug: AZD6244 |
| Registration date | Jun 30, 2011 |
| Target size | 18 |
| Secondary IDs | 11-C-0191;110191 |
| Registry page | clinicaltrials.gov |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: